0 102

Cited 0 times in

Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesis

Authors
 Hyun Jin Kim  ;  Jiae Lee  ;  Gong-Rak Lee  ;  Narae Kim  ;  Hye In Lee  ;  Minjeong Kwon  ;  Nam Young Kim  ;  Jin Ha Park  ;  Ye Hee Kang  ;  Hyeong Ju Song  ;  TaeSoo Kim  ;  Dong Min Shin  ;  Woojin Jeong 
Citation
 JOURNAL OF CELLULAR PHYSIOLOGY, Vol.236(12) : 8239-8252, 2021-12 
Journal Title
JOURNAL OF CELLULAR PHYSIOLOGY
ISSN
 0021-9541 
Issue Date
2021-12
MeSH
Animals ; Bone Resorption / drug therapy ; Bone Resorption / metabolism ; Calcineurin / metabolism ; Calcium Signaling / drug effects* ; Cell Differentiation / drug effects ; Flunarizine / antagonists & inhibitors* ; Flunarizine / metabolism ; Humans ; NFATC Transcription Factors / drug effects ; NFATC Transcription Factors / metabolism ; Osteoclasts / drug effects* ; Osteoclasts / metabolism ; Osteogenesis / drug effects* ; Osteogenesis / physiology ; Osteoporosis / drug therapy ; Osteoporosis / metabolism ; RANK Ligand / metabolism
Keywords
apoptosis ; calcium ; flunarizine ; osteoblast ; osteoclast
Abstract
Many bone diseases such as osteoporosis and periodontitis are caused by hyperactivation of osteoclasts. Calcium (Ca2+ ) signals are crucial for osteoclast differentiation and function. Thus, the blockade of Ca2+ signaling may be a strategy for regulating osteoclast activity and has clinical implications. Flunarizine (FN) is a Ca2+ channel antagonist that has been used for reducing migraines. However, the role of FN in osteoclast differentiation and function remains unknown. Here, we investigated whether FN regulates osteoclastogenesis and elucidated the molecular mechanism. FN inhibited osteoclast differentiation along with decreased expression of nuclear factor of activated T cells, cytoplasmic 1 (NFATc1), and attenuated osteoclast maturation and bone resorption. FN inhibition of osteoclast differentiation was restored by ectopic expression of constitutively active NFATc1. FN reduced calcium oscillations and its inhibition of osteoclast differentiation and resorption function was reversed by ionomycin, an ionophore that binds Ca2+ . FN also inhibited Ca2+ /calmodulin-dependent protein kinase IV (CaMKIV) and calcineurin leading to a decrease in the cAMP-responsive element-binding protein-dependent cFos and peroxisome proliferator-activated receptor-γ coactivator 1β expression, and NFATc1 nuclear translocation. These results indicate that FN inhibits osteoclastogenesis via regulating CaMKIV and calcineurin as a Ca2+ channel blocker. In addition, FN-induced apoptosis in osteoclasts and promoted osteogenesis. Furthermore, FN protected lipopolysaccharide- and ovariectomy-induced bone destruction in mouse models, suggesting that it has therapeutic potential for treating inflammatory bone diseases and postmenopausal osteoporosis.
Full Text
https://onlinelibrary.wiley.com/doi/10.1002/jcp.30496
DOI
10.1002/jcp.30496
Appears in Collections:
2. College of Dentistry (치과대학) > Dept. of Oral Biology (구강생물학교실) > 1. Journal Papers
Yonsei Authors
Shin, Dong Min(신동민) ORCID logo https://orcid.org/0000-0001-6042-0435
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/187626
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links